Results 301 to 310 of about 596,620 (345)
Some of the next articles are maybe not open access.
2021
Follicular lymphoma (FL) is an indolent yet challenging disease. Despite a generally favorable response to immunochemotherapy regimens, a fraction of patients does not respond or relapses early with unfavorable prognosis. For the vast majority of those who initially respond, relapses will repeatedly occur with increasing refractoriness to available ...
Milpied, Pierre +6 more
openaire +3 more sources
Follicular lymphoma (FL) is an indolent yet challenging disease. Despite a generally favorable response to immunochemotherapy regimens, a fraction of patients does not respond or relapses early with unfavorable prognosis. For the vast majority of those who initially respond, relapses will repeatedly occur with increasing refractoriness to available ...
Milpied, Pierre +6 more
openaire +3 more sources
Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma.
Blood, 2012Abstract Abstract 2648 Follicular lymphoma (FL) is an indolent lymphoma and the second most common type of non-Hodgkin lymphoma in the Western world. It is characterized by the t(14;18) chromosomal translocation, which is present in up to 90% of cases.
Wright, George W +22 more
openaire +2 more sources
Treatment of follicular lymphoma
Current Opinion in Oncology, 1998Follicular lymphoma is one of the most common neoplastic lymphoproliferative diseases encountered in the western world. Intensive scientific scrutiny has led to detailed understanding of the nature of the malignant cell and the specific genetic abnormalities which are frequently encountered and likely to be etiologic.
J M, Connors, R, Klasa
openaire +2 more sources
Obinutuzumab in follicular lymphoma
Drugs of Today, 2016The CD20 marker continues to be exploited as a therapeutic target for non-Hodgkin's lymphoma. Obinutuzumab is part of a new generation of anti-CD20 monoclonal antibodies, which are synthesized using molecular engineering technology, resulting in novel target epitopes and unprecedented optimization of antibody-dependent cellular cytotoxicity and ...
Martinez-Calle, N. (Nicolas) +4 more
openaire +3 more sources
Intramuscular Follicular Lymphoma
Clinical Nuclear Medicine, 2018Abstract We present an interesting image of a painless growing mass of the right arm in a 76-year-old man. A musculoskeletal MRI of the right arm showed a 7.5 × 3-cm homogeneous, well-defined mass, elongated along the course of muscle fascias and independent of the adjacent bone.
Martins F +4 more
openaire +3 more sources
Management of follicular lymphoma
Current Opinion in Oncology, 1994Despite the fact that a small proportion of patients with follicular lymphoma may be alive 20 years after the initial diagnosis, and that it is repeatedly, albeit usually only partially, responsive to relatively mild therapy, the disease remains stubbornly incurable for the majority.
A, Rohatiner, T A, Lister
openaire +2 more sources
Radiology, 1959
The diseases classified under the heading of malignant lymphoma have in common erratic proliferation of lymphoid tissue and an inevitably fatal outcome. Yet, within the group, and even within any of its subgroups, there occur wide variations in the rapidity and extent of lymphoid involvement of the various organs and in the survival time after onset of
I F, HUMMON, M, MAGALOTTI, E R, GRIGG
openaire +2 more sources
The diseases classified under the heading of malignant lymphoma have in common erratic proliferation of lymphoid tissue and an inevitably fatal outcome. Yet, within the group, and even within any of its subgroups, there occur wide variations in the rapidity and extent of lymphoid involvement of the various organs and in the survival time after onset of
I F, HUMMON, M, MAGALOTTI, E R, GRIGG
openaire +2 more sources
Hematological Oncology, 2023
AbstractThe past two decades have seen remarkable progress in both biological understanding and optimizing treatment of follicular lymphoma. Historically considered an incurable disease, long‐term follow‐up of several induction approaches demonstrates that up to 40% of patients enjoy remission durations of 10 or more years, and risk of dying of ...
openaire +2 more sources
AbstractThe past two decades have seen remarkable progress in both biological understanding and optimizing treatment of follicular lymphoma. Historically considered an incurable disease, long‐term follow‐up of several induction approaches demonstrates that up to 40% of patients enjoy remission durations of 10 or more years, and risk of dying of ...
openaire +2 more sources
The Management of Follicular Lymphoma
Drugs, 1994Follicular lymphoma is demonstrably incurable with conventional treatment. A number of strategies have prolonged the duration of remission. However, none have convincingly improved survival. The following new treatment modalities are currently being evaluated: Interferon, given either alone, in combination with conventional chemotherapy or as ...
A Z, Rohatiner, T A, Lister
openaire +2 more sources
Radioimmunotherapy in follicular lymphoma
Best Practice & Research Clinical Haematology, 2011The exquisite sensitivity of haematological malignancies to targeted radiation make Radioimmunotherapy (RIT) a theoretically attractive therapeutic approach. Furthermore, impressive results initially achieved by the pioneers in this field and more recently in larger studies have demonstrated the high clinical activity of RIT in follicular NHL (FL). For
Illidge, Tim; id_orcid 0000-0003-3191-7324 +1 more
openaire +3 more sources